PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
1 other identifier
interventional
90
1 country
1
Brief Summary
Purpose: The "Total Mesorectal Excision" (TME) is the standard surgical technique for the treatment of rectal cancer. Up to 50% of sexual dysfunction is described after TME and up to 30% of urinary dysfunction. The main objective of the study is to compare pre- and post-TME sexual dysfunction according to the approach of the inferior mesenteric vessels, directly on the IMA or from the inferior mesenteric vein (IMV) to the IMA. Methods: Multicenter, prospective, controlled and randomized study of patients with rectal adenocarcinoma with neoadjuvant chemoradiotherapy, who will be randomized into two groups depending on the approach of the inferior mesenteric vessels. The main variable is pre and postoperative sexual dysfunction. The sample to be included will be 90 patients, 45 per group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2018
CompletedFirst Posted
Study publicly available on registry
May 9, 2018
CompletedStudy Start
First participant enrolled
September 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedJune 25, 2018
June 1, 2018
3.3 years
April 3, 2018
June 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in sexual dysfunction pre- and post-Total Mesorectal Excision
Sexual dysfunction pre- and post-Total Mesorectal Excision by sexual dysfunction scale IIEF-5
1 week before surgery and 12 months post-surgery
Study Arms (2)
Inferior mesenteric Vein dissection
EXPERIMENTALTo improve and preserve the rectal nerve in the total mesorectal excision, its starts the dissection from the inferior mesenteric vein to the inferior mesenteric artery and through the pelvis
Inferior mesenteric Artery dissection
ACTIVE COMPARATORAs standard, the dissection starts straight in the inferior mesenteric artery and through the pelvis
Interventions
Dissection of the Inferior mesenteric Vein first, and go down to the Artery during the total mesorectal excision
Dissection of the Inferior mesenteric Artery directly in the total mesorectal excision
Eligibility Criteria
You may qualify if:
- Males;
- Age greater (or equal) to 18 years
- Diagnosed of rectal adenocarcinoma at ≤ 15 cm from the anal margin (by rigid rectoscopy)
- Candidate for neoadjuvant (chemoradiotherapy).
- Scheduled laparoscopic radical TME surgery carried out by colorectal surgeons;
- ASA I, II or III;
- Informed consent present.
You may not qualify if:
- women
- Under 18 years old;
- Not Candidate for neoadjuvant (chemoradiotherapy);
- Emergency surgery;
- Recurrent neoplasms
- cT4
- Patient with a history of infra-abdominal, or pelvic surgery of the prostate, or radiotherapy prior to the current process;
- Patients with severe sexual dysfunction and neurological alterations before surgery
- Patients with neurogenic bladder before surgery.
- Not to sign the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corporacion Parc Taulilead
- Paula Planelles-Solercollaborator
- Laura Mora-Lopezcollaborator
- Naim Hannaouicollaborator
- Sheila Serra-Placollaborator
- Arturo Dominguez-Garciacollaborator
- Jesus Muñoz-Rodriguezcollaborator
- Joan Prats-Lopezcollaborator
- Salvador Navarro-Sotocollaborator
- Xavier Serra-Aracilcollaborator
Study Sites (1)
Parc Tauli University Hospital
Sabadell, Barcelona, 08208, Spain
Related Publications (1)
Pallisera-Lloveras A, Planelles-Soler P, Hannaoui N, Mora-Lopez L, Munoz-Rodriguez J, Serra-Pla S, Dominguez-Garcia A, Prats-Lopez J, Navarro-Soto S, Serra-Aracil X; Tauli-Colorectal Cancer Study Group. Dissection of the inferior mesenteric vein versus of the inferior mesenteric artery for the genitourinary function after laparoscopic approach of rectal cancer surgery: a randomized controlled trial. BMC Urol. 2019 Aug 5;19(1):75. doi: 10.1186/s12894-019-0501-5.
PMID: 31382934DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Pallisera-Lloveras, MD, PhD
Corporacio Parc Tauli. Parc Tauli University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The analysis of the results will be blind for the investigator
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- md, PhD
Study Record Dates
First Submitted
April 3, 2018
First Posted
May 9, 2018
Study Start
September 3, 2018
Primary Completion
December 30, 2021
Study Completion
December 30, 2022
Last Updated
June 25, 2018
Record last verified: 2018-06